Armelle Poujol-Robert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Armelle Poujol-Robert has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Annie Robert
Université Pierre et Marie Curie
1 shared publicationDominique Wendum
Université Pierre et Marie Curie
1 shared publication- Pierre-Yves Boëlle
Sorbonne Université, INSERM, Sorbonne Public Health Institute, AP-HP, Hôpital Saint-Antoine, Paris, France
1 shared publication Raoul Poupon
Université Pierre et Marie Curie
1 shared publication
Latest Publications
- 22 August 2006
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (9) , 1633-1636
Association Between ABO Blood Group and Fibrosis Severity in Chronic Hepatitis C Infection
The progression of fibrosis in hepatitis C virus (HCV) infection is a process in which genes interact with environmental factors. A “clotting process” is involved in fibrogenesis. ABO blood group distribution is associated with thrombotic disease, non-O blood group increasing the risk of venous thrombosis. The aim of the study was to investigate whether ABO blood type contributes to the severity of fibrosis. We studied blood group distribution in 346 French patients with HCV infection who underwent biopsies. The distribution of non-O blood group was 40%, 55%, 62%, 71%, and 73% for the F0, F1, F2, F3 and F4 fibrosis scores, respectively. Non-O blood group was associated with increased severity of fibrosis, even after adjustment on gender, age, duration of infection, and alcohol consumption (odds ratio 1.8, 95% confidence interval 1.0–2.9; P=.04). Non-O blood group is an independent risk factor for the progression of liver fibrosis in HCV infection.
- 22 August 2006
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (9) , 1633-1636
Association Between ABO Blood Group and Fibrosis Severity in Chronic Hepatitis C Infection
The progression of fibrosis in hepatitis C virus (HCV) infection is a process in which genes interact with environmental factors. A “clotting process” is involved in fibrogenesis. ABO blood group distribution is associated with thrombotic disease, non-O blood group increasing the risk of venous thrombosis. The aim of the study was to investigate whether ABO blood type contributes to the severity of fibrosis. We studied blood group distribution in 346 French patients with HCV infection who underwent biopsies. The distribution of non-O blood group was 40%, 55%, 62%, 71%, and 73% for the F0, F1, F2, F3 and F4 fibrosis scores, respectively. Non-O blood group was associated with increased severity of fibrosis, even after adjustment on gender, age, duration of infection, and alcohol consumption (odds ratio 1.8, 95% confidence interval 1.0–2.9; P=.04). Non-O blood group is an independent risk factor for the progression of liver fibrosis in HCV infection.